TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention

[1] Frangogiannis NG(1998)Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion Circulation 98 699-710

[2] Lindsey ML(1999)Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts Circ Res 84 392-400

[3] Michael LH(2003)Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers Cardiovasc Res 60 608-616

[4] Youker KA(2010)TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure Pharmacol Ther 127 295-314

[5] Bressler RB(2002)Coronary microembolization: the role of TNF-alpha in contractile dysfunction J Mol Cell Cardiol 34 51-62

[6] Mendoza LH(2010)Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction Clin Res Cardiol 99 315-322

[7] Spengler RN(2012)In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty Clin Res Cardiol 101 37-44

[8] Smith CW(2011)Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction Clin Res Cardiol 100 1069-1076

[9] Entman ML(2005)Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur Heart J 26 1964-1970

[10] Kupatt C(1995)Cardiac release of cytokines and inflammatory responses in acute myocardial infarction Circulation 92 748-755

[1] Frangogiannis NG(1998)Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion Circulation 98 699-710

[2] Lindsey ML(1999)Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts Circ Res 84 392-400

[3] Michael LH(2003)Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers Cardiovasc Res 60 608-616

[4] Youker KA(2010)TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure Pharmacol Ther 127 295-314

[5] Bressler RB(2002)Coronary microembolization: the role of TNF-alpha in contractile dysfunction J Mol Cell Cardiol 34 51-62

[6] Mendoza LH(2010)Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction Clin Res Cardiol 99 315-322

[7] Spengler RN(2012)In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty Clin Res Cardiol 101 37-44

[8] Smith CW(2011)Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction Clin Res Cardiol 100 1069-1076

[9] Entman ML(2005)Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur Heart J 26 1964-1970

[10] Kupatt C(1995)Cardiac release of cytokines and inflammatory responses in acute myocardial infarction Circulation 92 748-755